SVNS — Solvonis Therapeutics Share News
0.000.00%
- £22.41m
- £20.77m
- 21
- 10
- 91
- 30
REG - Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with Chairman
AnnouncementREG - Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress
AnnouncementRCS - Solvonis Therapeutic - Investor Presentation
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with CEO
AnnouncementREG - Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn
Announcement